Agenda

Articles

• FEDER
  16 March 2022, by Jonathan NOWAK

  Vect Horus a reçu l’accord de la Région Sud Provence-Alpes-Côte d’Azur, responsable de la mise en œuvre du dispositif REACT-EU dans le cadre du Programme Opérationnel FEDER-FSE, pour une subvention de 1 146 069 €.
  Vect-Horus développe sa plateforme technologique VECTrans® unique en Europe dont l’objectif est de développer des molécules « vecteurs » qui permettent le ciblage et la délivrance d’agents d’imagerie ou thérapeutiques dans des organes spécifiques. Cette stratégie est centrale, en (…)

• Vect-Horus Nominated for the 2024 Biotech Trophy Award, Organized by France Biotech
  21 March 2024, by Emmanuelle BETTENDORF

  Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced it has been nominated for the 2024 Biotech Trophy award, organized by the France Biotech industry association.
  The award recognizes a biotech company which has distinguished itself in the past two years by particularly remarkable advances in R&D, operational development, partnerships or (…)

• Meet Vect-Horus at San Diego, California, June 3-6, 2024
  21 May 2024, by Emmanuelle BETTENDORF

  Next month, Emmanuelle Bettendorf will be attending the BIO International Convention, a major biotech industry conference taking place in San Diego, CA from June 3-6, 2024, and will be available to meet with you on partnership opportunities.
  Looking forward to seeing you there!

• Meet Vect-Horus at OTS, Montreal, October 6-9, 2024
  2 October 2024, by Emmanuelle BETTENDORF

  Guillaume Jacquot and Emmanuelle Bettendorf will be representing Vect-Horus at the The Oligonucleotide Therapeutics Society (OTS) Annual Meeting, taking place in Montreal, Canada from October 6-9.
  This is the leading international meeting of renowned oligonucleotide scientists, bringing academia, research and business together, and we are excited to swap notes with other leading players in the field.
  👉 Click here for more on the meeting www.2024oligomeeting.com

• Happy new year !
  2 January 2024, by Emmanuelle BETTENDORF

  The Vect-Horus teams join to wish you a Happy Holiday season and Best Wishes for 2024.

• Meet Vect-Horus at BIOTECH SHOWCASE, San Francisco, January 8-10, 2024
  20 December 2023, by Emmanuelle BETTENDORF

  From January 8 to 10, Emmanuelle Bettendorf will participate in the #BiotechShowcase at #JPM24 and will be available to meet with you on partnership opportunities.

• Boulder Peptide Symposium
  28 January 2019, by Jonathan NOWAK

  VECT-HORUS to Present at Boulder Peptide Symposium 2015

• Vect-Horus will be attending BIO Europe from the 24th - 26th October in Germany
  20 October 2022, by Elodie DORMES

  This is the first in person BIOEurope since 2019 and we are excited to meet everyone face-to-face again.
  Feel free to connect with Emmanuelle BETTENDORF on the platform for a meeting/coffee to discuss our DrugDelivery platform, amongt others in Neurodegenerative, Muscular, Cardiovascular and Eye diseases.

• Vect-Horus will be attending the BiotechShowcase 23
  12 January 2023, by Elodie DORMES

  From January 18 to 19, Emmanuelle Bettendorf will participate in the virtual #BiotechShowcase at #JPM23 and will be available to e-meet with you on partnership opportunities.

• Vect-Horus attends to the NLSDays
  29 April 2021, by Elodie DORMES

  Connect with Emmanuelle BETTENDORF Sr. Business Developer at this year’s digital NORDIC LIFE SCIENCES through the event’s One-on-One Partnering.